Cinzia Pellizzaro

825 total citations
21 papers, 678 citations indexed

About

Cinzia Pellizzaro is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cinzia Pellizzaro has authored 21 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Cinzia Pellizzaro's work include Estrogen and related hormone effects (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Breast Cancer Treatment Studies (4 papers). Cinzia Pellizzaro is often cited by papers focused on Estrogen and related hormone effects (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Breast Cancer Treatment Studies (4 papers). Cinzia Pellizzaro collaborates with scholars based in Italy. Cinzia Pellizzaro's co-authors include Danila Coradini, Maria Grazia Daidone, A Perbellini, Giuliana Miglierini, G. Di Fronzo, Silvia Veneroni, Danilo Marimpietri, Silvia Cantoni, Ignazio Scarlata and Sonia Zorzet and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Cinzia Pellizzaro

21 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cinzia Pellizzaro Italy 16 428 214 164 114 76 21 678
Yi He Ling United States 12 580 1.4× 381 1.8× 113 0.7× 92 0.8× 54 0.7× 15 855
Chiara Costanzo Italy 16 641 1.5× 301 1.4× 170 1.0× 83 0.7× 128 1.7× 20 970
András Jeney Hungary 18 438 1.0× 222 1.0× 189 1.2× 190 1.7× 25 0.3× 46 781
Jin Gao China 13 352 0.8× 224 1.0× 107 0.7× 46 0.4× 41 0.5× 39 702
Elizabeth Alli United States 12 483 1.1× 406 1.9× 194 1.2× 191 1.7× 29 0.4× 19 819
Shou-Ching Tang United States 18 468 1.1× 238 1.1× 117 0.7× 55 0.5× 22 0.3× 37 767
Rongjian Su China 16 410 1.0× 125 0.6× 101 0.6× 146 1.3× 101 1.3× 27 654
Corina Marx United States 10 438 1.0× 227 1.1× 324 2.0× 56 0.5× 25 0.3× 13 813
Biagio Pucci Italy 19 614 1.4× 141 0.7× 189 1.2× 56 0.5× 58 0.8× 33 918
Sourav Banerjee United Kingdom 16 653 1.5× 180 0.8× 105 0.6× 177 1.6× 26 0.3× 33 973

Countries citing papers authored by Cinzia Pellizzaro

Since Specialization
Citations

This map shows the geographic impact of Cinzia Pellizzaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinzia Pellizzaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinzia Pellizzaro more than expected).

Fields of papers citing papers by Cinzia Pellizzaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cinzia Pellizzaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinzia Pellizzaro. The network helps show where Cinzia Pellizzaro may publish in the future.

Co-authorship network of co-authors of Cinzia Pellizzaro

This figure shows the co-authorship network connecting the top 25 collaborators of Cinzia Pellizzaro. A scholar is included among the top collaborators of Cinzia Pellizzaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cinzia Pellizzaro. Cinzia Pellizzaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pellizzaro, Cinzia, Sonia Zorzet, Gianni Sava, et al.. (2008). Inhibition of Human Pancreatic Cell Line MIA PaCa2 Proliferation by HA-But, a Hyaluronic Butyric Ester. Pancreas. 36(4). e15–e23. 19 indexed citations
2.
Coradini, Danila, Cinzia Pellizzaro, Ignazio Scarlata, et al.. (2006). A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results. Leukemia. 20(5). 785–792. 14 indexed citations
3.
Pellizzaro, Cinzia, et al.. (2005). Hyaluronic acid butyric esters in cancer therapy. Anti-Cancer Drugs. 16(4). 373–379. 16 indexed citations
4.
Coradini, Danila, Cinzia Pellizzaro, Marco Bosco, et al.. (2004). Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: A preclinical study. Investigational New Drugs. 22(3). 207–217. 32 indexed citations
5.
Coradini, Danila, et al.. (2004). Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens. Cellular and Molecular Life Sciences. 61(1). 76–82. 31 indexed citations
6.
Coradini, Danila, Sonia Zorzet, Raffaella Rossin, et al.. (2004). Inhibition of Hepatocellular Carcinomas in vitro and Hepatic Metastases in vivo in Mice by the Histone Deacetylase Inhibitor HA-But. Clinical Cancer Research. 10(14). 4822–4830. 76 indexed citations
7.
Coradini, Danila, Elia Biganzoli, Cinzia Pellizzaro, et al.. (2003). Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen. British Journal of Cancer. 89(2). 268–270. 15 indexed citations
8.
Pellizzaro, Cinzia. (2002). Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. Carcinogenesis. 23(5). 735–740. 53 indexed citations
9.
10.
Coradini, Danila, Patrizia Boracchi, Maria Grazia Daidone, et al.. (2001). Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer. British Journal of Cancer. 85(6). 795–797. 21 indexed citations
11.
Pellizzaro, Cinzia, et al.. (2001). Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines. International Journal of Cancer. 91(5). 654–657. 39 indexed citations
12.
Coradini, Danila, et al.. (2000). Sodium butyrate modulates cell cycle‐related proteins in HT29 human colonic adenocarcinoma cells. Cell Proliferation. 33(3). 139–146. 64 indexed citations
13.
Coradini, Danila, Maria Grazia Daidone, Patrizia Boracchi, et al.. (2000). Time-Dependent Relevance of Steroid Receptors in Breast Cancer. Journal of Clinical Oncology. 18(14). 2702–2709. 48 indexed citations
14.
Pellizzaro, Cinzia, Danila Coradini, Silvia Morel, et al.. (2000). Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery.. PubMed. 19(5B). 3921–5. 19 indexed citations
15.
Coradini, Danila, Cinzia Pellizzaro, Giuliana Miglierini, Maria Grazia Daidone, & A Perbellini. (1999). Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti-proliferative activity on a breast-cancer cell line. International Journal of Cancer. 81(3). 411–416. 91 indexed citations
16.
Biffi, Annalisa, et al.. (1999). Simultaneous but not sequential treatment with sodium butyrate improves the antiproliferative effect of alpha- or beta-interferon on a breast cancer cell line.. PubMed. 18(6A). 4109–14. 3 indexed citations
17.
Coradini, Danila, Cinzia Pellizzaro, Alice Biffi, et al.. (1998). Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines.. PubMed. 18(1A). 177–82. 4 indexed citations
18.
Coradini, Danila, et al.. (1997). Combined Effect of Tamoxifen or Interf eron-β and 4-Hydroxyphenylretinamide on the Growth of Breast Cancer Cell Lines. Tumor Biology. 18(1). 22–29. 29 indexed citations
19.
Coradini, Danila, et al.. (1997). Effect of sodium butyrate on human breast cancer cell lines. Cell Proliferation. 30(3-4). 149–159. 37 indexed citations
20.
Coradini, Danila, et al.. (1997). Effect of sodium butyrate on human breast cancer cell lines. Cell Proliferation. 30(3). 149–159. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026